Examining the bidirectional association between emotion recognition and ASD symptoms using observational and genetic analyses - Reed, Zoe E.; Mahedy, Liam; Jackson, Abigail; Smith, George Davey; Penton-Voak, Ian; Attwood, Angela S; Munafò, Marcus R (medRxiv, 2020)
Background There is mixed evidence for an association between autism spectrum disorder (ASD) and emotion recognition deficits. We sought to assess the bidirectionality of this association using phenotypic and genetic data in a large community sample.Methods Analyses were conducted in three stages. First, we examined the bidirectional association between ASD symptoms at age 16 years and emotion recognition task (ERT) responses at age 24 years (Study 1; N=3,579); and between Diagnostic Analysis of Nonverbal Accuracy (DANVA) emotion recognition responses at age 8 years and ASD symptoms at age 16 years (Study 2; N=8,545). Next, we examined the association between these phenotypes and polygenic risk scores for these. Finally, the genetic correlation between ASD and ERT responses at age 24 was estimated. Analyses were conducted in the Avon Longitudinal Study of Parents and Children.Results ASD symptoms at age 16 years were associated with later total correct responses on ERT in Study 1 (ß=-0.17; 95% CI: -0.26 to -0.08). However, there was no clear evidence of an association in Study 2 after adjusting for confounders (ß=-0.004; 95% CI: -0.03 to 0.02). We observed a negative association between ERT polygenic risk score and ASD symptoms (ß=-0.23; 95% CI: -0.33 to -0.13;).However, we found the opposite association between the ASD polygenic risk score and ERT (ß=0.40; 95% CI: 0.10 to 0.70). We observed a moderate genetic correlation between ASD and ERT (r=0.30), but the statistical evidence for this was very weak.Conclusion We found an observational association between poorer emotion recognition and increased ASD symptoms. Our genetic analyses revealed an association between ERT polygenic risk scores and ASD symptoms, which may suggest a shared genetic aetiology between these or a potential causal pathway. Our results may inform interventions targeting emotion recognition.Competing Interest StatementIPV and MRM are co-directors of Jericoe Ltd. a company that licenses software for the assessment and modification of emotion recognition. All other authors have declared that they have no competing or potential conflicts of interest.Funding StatementThis work was supported in part by the UK Medical Research Council Integrative Epidemiology Unit at the University of Bristol (Grant ref: MC_UU_00011/7). The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and ZER, LM, AJ, GDS, IPV, ASA and MRM will serve as guarantors for the contents of this paper. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). GWAS data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. ZER is supported by the Elizabeth Blackwell Institute for Health Research, University of Bristol and the Wellcome Trust Institutional Strategic Support Fund (Grant ref:204813/Z/16/Z). LM is supported by the Elizabeth Blackwell Institute for Health Research, University of Bristol and the Wellcome Trust Institutional Strategic Support Fund (Grant ref: 204813/Z/16/Z). IPV and MRM are supported by the National Institute for Health Research Bristol Biomedical Research Centre.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Informed consent for the use of data collected via questionnaires and clinics was obtained from participants following the recommendations of the ALSPAC Ethics and Law Committee at the time.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe ALSPAC data management plan (http://www.bristol.ac.uk/alspac/researchers/data-access/documents/alspac-data-management-plan.pdf) describes in detail the policy regarding data sharing, which is through a system of managed open access. The steps below highlight how to apply for access to the data included in this paper and all other ALSPAC data. The datasets used in this analysis are linked to ALSPAC project number B3113; please quote this project number during your application. 1. Please read the ALSPAC access policy (PDF, 627 kB) which describes the process of accessing the data and samples in detail, and outlines the costs associated with doing so. 2. You may also find it useful to browse the fully searchable ALSPAC research proposals database, which lists all research projects that have been approved since April 2011. 3. Please submit your research proposal for consideration by the ALSPAC Executive Committee. You will receive a response within 10 working days to advise you whether your proposal has been approved. If you have any questions about accessing data, please email alspac-data@bristol.ac.uk.